rubidium has been researched along with neurotensin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boroni, F; Castelletti, L; Dal Toso, R; Gabellini, N; Missale, C; Sigala, S; Spano, P | 1 |
Franklin, CC; Kim, HD; Turner, JT; Wu, H | 1 |
2 other study(ies) available for rubidium and neurotensin
Article | Year |
---|---|
Lack of coupling of D-2 receptors to adenylate cyclase in GH-3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes.
Topics: Adenylyl Cyclases; Amino Acid Sequence; Animals; Base Sequence; Cell Membrane; Colforsin; Cyclic AMP; DNA; Dopamine; Dopamine Agents; Dopamine Antagonists; Epidermal Growth Factor; Ergolines; GTP-Binding Proteins; Molecular Sequence Data; Neurotensin; Potassium Channels; Prolactin; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Rubidium; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1991 |
Regulation of calcium-activated potassium efflux by neurotensin and other agents in HT-29 cells.
Topics: Adenocarcinoma; Adenosine Triphosphate; Barium; Calcium; Carbachol; Cell Line; Colonic Neoplasms; Humans; Ionomycin; Kinetics; Neurotensin; Potassium; Potassium Channels; Rubidium; Tetradecanoylphorbol Acetate; Tetraethylammonium; Tetraethylammonium Compounds | 1991 |